Data Intelligence, Business Analytics
"If the low prices seem too good to be true, they probably are", claims the FDA on an article dated September 28 and distributed to major news outlets. The truth is "If the high prices (in US) seem too high to be fair, they probably are (unfair). The real cause of the problems is that prices are 10 times too high in US for a brand name drug, compared with the same generic drug manufactured in China.
The prices in US are artificially supported - it is a highly regulated market with collusion between drug makers and the government to inflate prices. Indeed the FDA used to buy Google ads for keywords such as "online pharmacy", saying that "it is a felony to purchase drugs abroad".
What is wrong with this?
By the way, a website such as Yelp could help rank online pharmacies to decide which ones are bad or good. We don't need the FDA for that, crowd-sourcing works much better when spam issues are properly handled..